GLP Watchdog

Mochi Health vs Polly

Neither Mochi Health nor Polly has an FDA warning letter on record. No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Mochi Health / Polly

Mochi Health logo

Mochi Health

7.1/10

Polly logo

Polly

8.4/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$110/moFoundayo (orforglipron) pill
$179/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked November 2026
Visit Mochi Health
Visit Polly

Neither Mochi Health nor Polly pays us. Links to them earn nothing. Scores: Mochi Health 7.1, Polly 8.4. How we are paid

What the record shows

  1. 01

    Neither Mochi Health nor Polly has an FDA warning letter on record.

  2. 02

    Polly names two pharmacies, all 503A. Mochi Health names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

  4. 04

    Only Mochi Health lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.

  5. 05

    Mochi Health states you can cancel at any time; Polly does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Mochi Health

Polly

Compounded semaglutide injection

$139/mo

plan terms unclear; not compared

$179/mo

$2,148 a year

Compounded tirzepatide injection

$169/mo

plan terms unclear; not compared

$279/mo

$3,348 a year

Brand-name semaglutide pen

$199/mo

medication only, membership extra; not compared

Not sold or not priced
Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

Not sold or not priced
Compounded oral semaglutide

$141/mo

$1,692 a year

Not sold or not priced
Brand-name semaglutide pill

$149/mo

medication only, membership extra; not compared

Not sold or not priced
Foundayo (orforglipron) pill

$110/mo

$1,320 a year

Not sold or not priced
Price includes
Clinician visits, coaching
Medication, clinician visits, shipping
Billed separately
Medication
Not stated
Cancel any time
Yes, stated
Not stated
Minimum term
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
Month to month, or a 3- or 6-month supply charged at checkout
Refunds
No refunds for partly used periods; medication is not refundable once sent to the pharmacy
Full refund only before the medical intake is submitted; 3- and 6-month plans cannot be refunded once the first month has passed
Early-exit fee
Not stated
Yes

Read off each seller’s own pages. Mochi Health: October 31, 2026. Polly: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Mochi Health

7.1/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Polly does not price
  • States you can cancel at any time
  • Names no compounding pharmacy
  • Price leaves out medication
Visit Mochi Health

The case for Polly

8.4/10
  • Names its compounding pharmacy
Visit Polly

Scores

Mochi Health 7.1 · Polly 8.4 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

7.5A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
10.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

4.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Mochi Health vs Polly: questions

Neither Mochi Health nor Polly has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Polly names two pharmacies, all 503A. Mochi Health names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy. Polly does not state its cancellation terms.
Neither Mochi Health nor Polly pays us. Links to them earn nothing. Scores: Mochi Health 7.1, Polly 8.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks